{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:24:23Z","timestamp":1786965863736,"version":"build-2736575974"},"reference-count":44,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Accurate staging in gastric cancer is essential for optimal treatment planning. Diagnostic laparoscopy (DL) plays a crucial role in detecting occult peritoneal metastases not identified by conventional imaging. This study aimed to evaluate the impact of DL on clinical decision-making and treatment allocation in patients with gastric cancer. Methods: We retrospectively analyzed consecutive patients treated between June 2016 and March 2026 at a tertiary Surgical Oncology Center. All patients underwent diagnostic laparoscopy with peritoneal lavage and biopsies. Patients were stratified according to the Peritoneal Cancer Index (PCI) and directed to appropriate treatment pathways, including CRS + HIPEC, PIPAC combined with systemic chemotherapy, or neoadjuvant chemotherapy followed by surgical re-evaluation. Results: Occult peritoneal metastases were detected in 20% of patients (80\/400). Among patients with peritoneal metastasis, 70 patients ultimately underwent CRS + HIPEC and 39 underwent PIPAC-based treatment. Among these 70 patients, 53 patients with PCI &lt; 7 were initially allocated to CRS + HIPEC and an additional 17 patients with newly detected limited peritoneal disease (PCI &lt; 7) underwent CRS + HIPEC following restaging laparoscopy after neoadjuvant chemotherapy, resulting in a total of 70 patients in the CRS + HIPEC group. In the CRS + HIPEC group, the 1-year survival rate was 70% with a morbidity rate of 25.7%. In the PIPAC group, the 1-year survival rate was 50% with a morbidity rate of 25.6%. Among patients receiving neoadjuvant chemotherapy, disease progression was detected in 14% during restaging laparoscopy. Palliative surgery provided effective symptom control in inoperable patients, with a 1-year survival rate of approximately 15%. Conclusions: Diagnostic laparoscopy provides additional staging information and guides treatment allocation in patients with advanced gastric cancer. PCI-based assessment enables individualized selection of CRS + HIPEC, PIPAC, or systemic treatment strategies. However, the present study was not designed to determine whether DL-guided treatment allocation improves survival, and the observed survival outcomes should therefore be interpreted as descriptive real-world outcomes rather than evidence of treatment benefit.<\/jats:p>","DOI":"10.3390\/diagnostics16162590","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:04:36Z","timestamp":1786961076000},"page":"2590","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Diagnostic Laparoscopy in Staging and Treatment Planning of Gastric Cancer: A 400-Patient Retrospective Cohort Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-2459","authenticated-orcid":false,"given":"Tugce Kubra","family":"Gunes Capar","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, University of Health Sciences, Istanbul Umraniye Training and Research Hospital, Istanbul 34764, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-8639","authenticated-orcid":false,"given":"P\u0131r\u0131lt\u0131","family":"Ozcan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Biruni University, Istanbul 34015, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzeyyen Muge","family":"Savas","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Health Sciences, Istanbul Umraniye Training and Research Hospital, Istanbul 34764, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-2276","authenticated-orcid":false,"given":"Ozgul","family":"Duzgun","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Health Sciences, Istanbul Umraniye Training and Research Hospital, Istanbul 34764, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-715X","authenticated-orcid":false,"given":"Melike","family":"Ozcelik","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, University of Health Sciences, Istanbul Umraniye Training and Research Hospital, Istanbul 34764, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/bjs\/znab200","article-title":"Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without HIPEC (CYTO-CHIP study)","volume":"108","author":"Bonnot","year":"2021","journal-title":"Br. J. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.5230\/jgc.2025.25.e36","article-title":"Peritoneal oligometastasis in gastric cancer: Diagnostic Strategies, Patient Selection, and Emerging Therapeutic Approaches","volume":"25","author":"Kim","year":"2025","journal-title":"J. Gastric Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/curroncol31030109","article-title":"Peritoneal metastatic gastric cancer: Local treatment options and recommendations","volume":"31","author":"Acs","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13304-022-01399-y","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: A single-centre experience","volume":"75","author":"Allievi","year":"2023","journal-title":"Updates Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","article-title":"A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology","volume":"28","author":"Badgwell","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4174\/astr.2021.100.4.209","article-title":"Treatment options for advanced gastric cancer with peritoneal metastasis: Experience from a single institution in Korea","volume":"100","author":"Kim","year":"2021","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"goae001","DOI":"10.1093\/gastro\/goae001","article-title":"Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with intraoperative detection of limited peritoneal metastasis: A Phase II study of CLASS-05 trial","volume":"12","author":"Lin","year":"2024","journal-title":"Gastroenterol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ejso.2016.06.401","article-title":"Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis","volume":"42","author":"Ramos","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cossu, A., Calef, R., Puccetti, F., Foti, S., Cascinu, S., Rosati, R., Elmore, U., and OSR CCeR Collaborative Group (2025). Staging laparoscopy in high-risk gastric cancer: A decade of real-world evidence and therapeutic impact from a Tertiary Referral Center. Cancers, 18.","DOI":"10.3390\/cancers18010027"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Schena, C.A., Laterza, V., De Sio, D., Quero, G., Fiorillo, C., Gunawardena, G., Strippoli, A., Tondolo, V., de\u2019Angelis, N., and Alfieri, S. (2023). The role of staging laparoscopy for gastric cancer patients: Current Evidence and Future Perspectives. Cancers, 15.","DOI":"10.3390\/cancers15133425"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer","volume":"47","author":"Alyami","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108278","DOI":"10.1016\/j.ejso.2024.108278","article-title":"Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus Towards a standardized protocol","volume":"50","author":"Guchelaar","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1245\/s10434-021-10157-0","article-title":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of \u2018Italian Peritoneal Surface Malignancies Oncoteam\u2014S.I.C.O.\u2019","volume":"28","author":"Marano","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Manzanedo, I., Pereira, F., P\u00e9rez-Viejo, E., and Serrano, \u00c1. (2023). Gastric cancer with peritoneal metastases: Current status and prospects. Cancers, 15.","DOI":"10.3390\/cancers15061777"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Prabhu, A., Mishra, D., Brandl, A., and Yonemura, Y. (2022). Gastric cancer with peritoneal metastasis: A comprehensive review of current intraperitoneal treatment modalities. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.864647"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gronau, F., Feldbr\u00fcgge, L., Oberwittler, F., Gonzalez-Moreno, S., Villeneuve, L., Eveno, C., Glehen, O., Kusamura, S., and Rau, B. (2022). HIPEC in peritoneal metastasis of gastric origin: A systematic review of Regimens and Techniques. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051456"},{"key":"ref_19","first-page":"1948","article-title":"Perioperative chemotherapy with FLOT versus CF","volume":"393","author":"Homann","year":"2019","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone","volume":"355","author":"Cunningham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association (2021). Japanese gastric cancer treatment guidelines 2021. Gastric Cancer, 24, 1\u201321.","DOI":"10.1007\/s10120-020-01042-y"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","article-title":"Chemotherapy in advanced gastric cancer","volume":"24","author":"Wagner","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guidelines","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","article-title":"Gastric cancer","volume":"388","author":"Sagaert","year":"2016","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"NCCN Guidelines for gastric cancer","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_26","first-page":"1435","article-title":"DCF versus CF in metastatic gastric cancer","volume":"26","author":"Hartmann","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in gastric cancer (ToGA trial)","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy (REGARD trial)","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S1470-2045(18)30739-3","article-title":"Trifluridine\/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"19","author":"Shitara","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1097\/JS9.0000000000003901","article-title":"The survival and peritoneal metastasis of hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: A systematic review and meta-analysis of randomized controlled trials","volume":"112","author":"Zhang","year":"2026","journal-title":"Int. J. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jso.27877","article-title":"The Effects of HIPEC on Survival of Gastric Cancer Patients With Peritoneal Metastasis","volume":"130","author":"Ji","year":"2024","journal-title":"J. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000528609","article-title":"Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer","volume":"101","author":"Ozgun","year":"2023","journal-title":"Oncology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"oyaf219","DOI":"10.1093\/oncolo\/oyaf219","article-title":"Emerging treatment modalities for gastric cancer with peritoneal metastases: A systematic review","volume":"30","author":"Galanos","year":"2025","journal-title":"Oncologist"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: A multi-institutional study of 1,290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Yonemura, Y., Prabhu, A., Sako, S., Ishibashi, H., Mizumoto, A., Takao, N., Ichinose, M., Motoi, S., Liu, Y., and Nishihara, K. (2020). Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis. Cancers, 12.","DOI":"10.3390\/cancers12010116"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"goaf040","DOI":"10.1093\/gastro\/goaf040","article-title":"Pressurized Intraperitoneal Aerosol Chemotherapy in Advanced Gastric Cancer with Peritoneal Metastases: A Comprehensive Meta-Analysis of Feasibility, Efficacy, and Safety","volume":"13","author":"Chen","year":"2025","journal-title":"Gastroenterol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/annonc\/mdx236","article-title":"Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin\/S-1 and docetaxel\/cisplatin\/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer","volume":"28","author":"Aoyama","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejso.2021.08.003","article-title":"Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study","volume":"48","author":"Borgstein","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1097\/JS9.0000000000001826","article-title":"Efficacy and safety of robotic vs. laparoscopic gastrectomy for patients with gastric cancer: Systematic review and meta-analysis","volume":"110","author":"Li","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1245\/s10434-024-15103-4","article-title":"Impact of ^18F-FDG-PET\/CT and Laparoscopy in Staging of Locally Advanced Gastric Cancer: A Cost Analysis in the Prospective Multicenter PLASTIC-Study","volume":"31","author":"Gertsen","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jso.24942","article-title":"Diagnostic Staging Laparoscopy in Gastric Cancer Treatment: A Cost-Effectiveness Analysis","volume":"117","author":"Li","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"ref_42","first-page":"120","article-title":"Economic impact of laparoscopy","volume":"70","author":"Sugarbaker","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.21037\/atm-21-3001","article-title":"Application of artificial intelligence in gastrointestinal disease: A narrative review","volume":"9","author":"Zhou","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhao, K. (2026). Application of Artificial Intelligence in Gastrointestinal Disease. Diagnostics, 16.","DOI":"10.3390\/diagnostics16050723"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/16\/2590\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:27:20Z","timestamp":1786962440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/16\/2590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":44,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["diagnostics16162590"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16162590","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}